MCRB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Seres Therapeutics Inc (MCRB) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to support immediate investment. It is better to wait for clearer signs of recovery or growth before committing funds.
The technical indicators for MCRB are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 35.455, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot point of 9.106, with key support at 7.918 and resistance at 10.294.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data available.
Weak financial performance in Q3 2025, with a 90.76% drop in net income and a 91.92% drop in EPS YoY. Technical indicators are bearish, and there are no recent positive trading signals.
In Q3 2025, revenue remained flat at $351,000 (0.00% YoY growth). Net income dropped significantly by 90.76% YoY to $8,204,000, and EPS fell by 91.92% YoY to 0.94. Gross margin remained stable at 100%. Overall, the company is struggling with profitability.
No data available for analyst rating or price target changes.
